Structure, Nomenclature, and Function of Nucleosides and Nucleotides

Course and Curriculum Overview

  • Academic Institution: Faculty of Medicine, BADR University in Cairo (BUC).
  • Instructional Department: Molecular Cell Biology and Genetics.
  • Module Identifier: CBG 1103.
  • Instructional Faculty: Prof. Dr Dina Sabry and Dr/Shimaa Mohsen.
  • Module Purpose and Scope:
    • Equips medical students with the foundational principles of molecular biology and genetics.
    • Details molecular mechanisms responsible for governing the stability, integrity, and structural maintenance of the genetic material.
    • Utilizes clinical and pathological examples to illustrate the cellular, biochemical, and genetic basis of human diseases.
    • Applies fundamental scientific principles to solve clinical and medical problems.
  • Intended Learning Outcomes (ILOs):
    • Identify the structural components, chemistry, and systematic nomenclature of nucleotides and nucleosides.
    • Enumerate nucleotides of biological significance and articulate their precise physiological and metabolic functions.
    • Describe higher-order DNA architecture and elucidate the chemical mechanics of phosphodiester bond formation.

Nucleic Acid Chemistry and Structural Architecture

  • Definition and General Characteristics:
    • Nucleic acids, specifically deoxyribonucleic acid (DNA\text{DNA}) and ribonucleic acid (RNA\text{RNA}), represent biopolymers constructed from repeating linear arrays of monomeric building blocks termed nucleotides.
    • Nucleotides function both in polymerized macromolecular configurations (DNA\text{DNA} and RNA\text{RNA} chains) and as free, monomeric molecules executing crucial biochemical roles throughout the cell.

DNA double helix and single-stranded RNA architecture showing nitrogenous bases and sugar-phosphate backbones

  • Fundamental Components of a Nucleotide:
    • Every complete monomeric nucleotide consists of three covalently bonded constituents:
    • A nitrogenous base (purine or pyrimidine heterocyclic ring).
    • A five-carbon pentose sugar (ribose or 2′-deoxyribose2'\text{-deoxyribose}).
    • One or more phosphate groups (derived from phosphoric acid, H3PO4\text{H}_3\text{PO}_4).

General chemical structure of an individual nucleotide

The Pentose Sugar Component

  • Classification and Structural Stereochemistry:
    • Pentose sugars found in nucleic acids exist as five-membered furanose rings classified into two forms:
    • Ribose (D-ribofuranose\text{D-ribofuranose}): Present exclusively in ribonucleic acid (RNA\text{RNA}); contains a hydroxyl group (−OH-\text{OH}) bonded to carbon 2′2' (C2′\text{C}2').
    • Deoxyribose (2′-deoxy-D-ribofuranose2'\text{-deoxy-D-ribofuranose}): Present exclusively in deoxyribonucleic acid (DNA\text{DNA}); structurally characterized by the absence of an oxygen atom at carbon 2′2' (C2′\text{C}2'), possessing two hydrogen atoms (−H-\text{H}) bonded to this position instead of a hydroxyl moiety.

Structural chemical comparison of ribose in RNA and 2-deoxyribose in DNA

The Phosphate Group

  • Molecular Configuration and Linkage:
    • Derived from inorganic phosphoric acid (H3PO4\text{H}_3\text{PO}_4).
    • Covalently links to the carbon 5′5' (C5′\text{C}5') position of the pentose sugar via an ester bond (phosphoester linkage).
    • In extended nucleic acid polynucleotides, phosphate groups bridge adjacent sugars by forming a phosphodiester bond connecting the 3′-hydroxyl3'\text{-hydroxyl} of one pentose to the 5′-hydroxyl5'\text{-hydroxyl} of the subsequent pentose.

Chemical structure of phosphoric acid showing phosphorus bonded to oxygen and hydroxyl groups

Nitrogenous Bases

  • Nitrogenous Base Classification:
    • Nitrogen-containing heterocyclic aromatic ring systems classified into two distinct structural families:
    • Purines: Planar, bicyclic molecules consisting of a six-membered pyrimidine ring fused to a five-membered imidazole ring.
    • Pyrimidines: Planar, monocyclic six-membered heterocyclic rings containing two nitrogen atoms.

Skeletal ring structures comparing the purine bicycle and pyrimidine monocycle

  • Major Purine Bases:
    • Adenine (A\text{A}): 6-aminopurine6\text{-aminopurine}; possesses an exocyclic amino group (−NH2-\text{NH}_2) at carbon 6 (C6\text{C}6).
    • Guanine (G\text{G}): 2-amino-6-oxypurine2\text{-amino-6-oxypurine}; possesses an exocyclic amino group at carbon 2 (C2\text{C}2) and a carbonyl oxygen at carbon 6 (C6\text{C}6).
  • Major Pyrimidine Bases:
    • Cytosine (C\text{C}): 4-amino-2-oxypyrimidine4\text{-amino-2-oxypyrimidine}; found in both DNA\text{DNA} and RNA\text{RNA}; contains an amino group at C4\text{C}4 and a carbonyl group at C2\text{C}2.
    • Thymine (T\text{T}): 2,4-dioxy-5-methylpyrimidine2,4\text{-dioxy-5-methylpyrimidine}; found exclusively in DNA\text{DNA}; contains carbonyl groups at C2\text{C}2 and C4\text{C}4 and a unique methyl group (−CH3-\text{CH}_3) at carbon 5 (C5\text{C}5).
    • Uracil (U\text{U}): 2,4-dioxypyrimidine2,4\text{-dioxypyrimidine}; found exclusively in RNA\text{RNA}; contains carbonyl groups at C2\text{C}2 and C4\text{C}4 without methylation at C5\text{C}5.

Complete chemical structures of pyrimidines cytosine, uracil, thymine and purines adenine, guanine

  • Minor Purine Bases and Metabolic Intermediates:
    • Metabolic intermediates formed during purine degradation and biosynthesis, typically absent from mature primary nucleic acid chains:
    • Hypoxanthine: 6-oxypurine6\text{-oxypurine}; intermediate formed during the catabolism of adenosine.
    • Xanthine: 2,6-dioxypurine2,6\text{-dioxypurine}; formed by the oxidation of hypoxanthine or the deamination of guanine.
    • Uric Acid: 2,6,8-trioxypurine2,6,8\text{-trioxypurine}; end product of purine catabolism in humans.
    • Caffeine: 1,3,7-trimethylxanthine1,3,7\text{-trimethylxanthine}; pharmacologically active methylated purine derivative.

Structural formulas of purine metabolites uric acid, xanthine, hypoxanthine, and caffeine

Assembly and Chemistry of Nucleosides and Nucleotides

  • Nucleoside Synthesis and Chemical Bonding:
    • Formed by covalently coupling a nitrogenous base directly to carbon 1′1' (C1′\text{C}1') of a pentose sugar via an β-N-glycosidic\beta\text{-N-glycosidic} bond.
    • Regiospecific attachment points:
    • Purines: Atom nitrogen 9 (N9\text{N}9) covalently attaches to C1′\text{C}1' of the sugar.
    • Pyrimidines: Atom nitrogen 1 (N1\text{N}1) covalently attaches to C1′\text{C}1' of the sugar.
    • Chemical Equation: Nitrogenous base+Pentose sugar→Nucleoside\text{Nitrogenous base} + \text{Pentose sugar} \rightarrow \text{Nucleoside}.
  • Nucleotide Synthesis and High-Energy Bonding:
    • Formed when one, two, or three phosphate groups esterify to the hydroxyl group on carbon 5′5' (C5′\text{C}5') of the pentose sugar of a nucleoside.
    • Chemical Equation: Nucleoside+Phosphate group(s)→Nucleotide\text{Nucleoside} + \text{Phosphate group(s)} \rightarrow \text{Nucleotide}.
    • Energetics:
    • Nucleoside monophosphates contain a single low-energy ester linkage (C5′−O−P\text{C}5'-\text{O}-\text{P}).
    • Nucleoside diphosphates (NDP\text{NDP}) and nucleoside triphosphates (NTP\text{NTP}) possess additional phosphoanhydride bonds between successive phosphate groups.
    • Phosphoanhydride bonds are thermodynamically unstable and high-energy; cleavage releases substantial free energy (ΔG\Delta G) to drive endergonic cellular reactions.

High-energy phosphoanhydride bonds indicated within adenosine triphosphate

Nomenclature of Ribonucleosides and Ribonucleotides

  • Naming Standards for Ribose-Containing Compounds:
    • Bases, corresponding nucleosides, monophosphorylated acids, and higher-energy phosphorylated forms follow standardized nomenclature:
    • Adenine:
      • Ribonucleoside: Adenosine.
      • Monophosphate Nucleotide: Adenylic acid or Adenosine monophosphate (AMP\text{AMP}).
      • Diphosphate Nucleotide: Adenosine diphosphate (ADP\text{ADP}).
      • Triphosphate Nucleotide: Adenosine triphosphate (ATP\text{ATP}).
    • Guanine:
      • Ribonucleoside: Guanosine.
      • Monophosphate Nucleotide: Guanylic acid or Guanosine monophosphate (GMP\text{GMP}).
      • Diphosphate Nucleotide: Guanosine diphosphate (GDP\text{GDP}).
      • Triphosphate Nucleotide: Guanosine triphosphate (GTP\text{GTP}).
    • Cytosine:
      • Ribonucleoside: Cytidine.
      • Monophosphate Nucleotide: Cytidylic acid or Cytidine monophosphate (CMP\text{CMP}).
      • Diphosphate Nucleotide: Cytidine diphosphate (CDP\text{CDP}).
      • Triphosphate Nucleotide: Cytidine triphosphate (CTP\text{CTP}).
    • Uracil:
      • Ribonucleoside: Uridine.
      • Monophosphate Nucleotide: Uridylic acid or Uridine monophosphate (UMP\text{UMP}).
      • Diphosphate Nucleotide: Uridine diphosphate (UDP\text{UDP}).
      • Triphosphate Nucleotide: Uridine triphosphate (UTP\text{UTP}).
    • Hypoxanthine:
      • Ribonucleoside: Inosine.
      • Monophosphate Nucleotide: Inosine monophosphate (IMP\text{IMP}).
    • Xanthine:
      • Ribonucleoside: Xanthosine.
      • Monophosphate Nucleotide: Xanthosine monophosphate (XMP\text{XMP}).

Comprehensive nomenclature chart for ribonucleotides and ribonucleosides

Nomenclature of Deoxyribonucleosides and Deoxyribonucleotides

  • Naming Standards for 2′-Deoxyribose2'\text{-Deoxyribose}-Containing Compounds:
    • Utilizes the prefix "deoxy-" (abbreviated with lowercase "d") to denote the missing 2′-oxygen2'\text{-oxygen} atom:
    • Adenine:
      • Deoxyribonucleoside: Deoxyadenosine.
      • Monophosphate Nucleotide: Deoxyadenylic acid or Deoxyadenosine monophosphate (dAMP\text{dAMP}).
      • Diphosphate Nucleotide: Deoxyadenosine diphosphate (dADP\text{dADP}).
      • Triphosphate Nucleotide: Deoxyadenosine triphosphate (dATP\text{dATP}).
    • Guanine:
      • Deoxyribonucleoside: Deoxyguanosine.
      • Monophosphate Nucleotide: Deoxyguanylic acid or Deoxyguanosine monophosphate (dGMP\text{dGMP}).
      • Diphosphate Nucleotide: Deoxyguanosine diphosphate (dGDP\text{dGDP}).
      • Triphosphate Nucleotide: Deoxyguanosine triphosphate (dGTP\text{dGTP}).
    • Cytosine:
      • Deoxyribonucleoside: Deoxycytidine.
      • Monophosphate Nucleotide: Deoxycytidylic acid or Deoxycytidine monophosphate (dCMP\text{dCMP}).
      • Diphosphate Nucleotide: Deoxycytidine diphosphate (dCDP\text{dCDP}).
      • Triphosphate Nucleotide: Deoxycytidine triphosphate (dCTP\text{dCTP}).
    • Thymine:
      • Deoxyribonucleoside: Deoxythymidine (often referred to simply as thymidine).
      • Monophosphate Nucleotide: Deoxythymidylic acid or Deoxythymidine monophosphate (dTMP\text{dTMP}).
      • Diphosphate Nucleotide: Deoxythymidine diphosphate (dTDP\text{dTDP}).
      • Triphosphate Nucleotide: Deoxythymidine triphosphate (dTTP\text{dTTP}).

Comprehensive nomenclature chart for deoxyribonucleotides and deoxyribonucleosides

Specialized Nucleotides of Biological Significance

  • S-Adenosylmethionine (SAM\text{SAM}):
    • Structure: Formed by the enzymatic condensation of adenosine triphosphate (ATP\text{ATP}) and the amino acid methionine, creating a positively charged sulfonium center (S+\text{S}^+).
    • Biological Function: Primary methyl group (−CH3-\text{CH}_3) donor in cellular transmethylation reactions, transferring methyl groups to DNA\text{DNA}, RNA\text{RNA}, proteins, and membrane phospholipids.

Structural formula of S-adenosylmethionine highlighting methyl, methionine, and adenosine domains

  • 3′-Phosphoadenosine-5’-phosphosulfate3'\text{-Phosphoadenosine-5'-phosphosulfate} (PAPS\text{PAPS}):
    • Structure: Adenosine derivative containing a phosphate esterified at carbon 3′3' and a mixed anhydride bond between a 5′-phosphate5'\text{-phosphate} and a sulfate group (−SO3−-\text{SO}_3^-).
    • Biological Function: Active, high-energy sulfate donor utilized by sulfotransferases for the biosynthesis of sulfated glycosaminoglycans, sulfolipids, and the phase II detoxification of xenobiotics.

Chemical structure of phosphoadenosine-phospho-sulfate illustrating sulfate and adenosine moieties

  • Cyclic Adenosine Monophosphate (cAMP\text{cAMP}):
    • Structure: Mononucleotide containing an intramolecular diester bond formed between the phosphate group and both the carbon 3′3' (C3′\text{C}3') and carbon 5′5' (C5′\text{C}5') hydroxyl positions of the same ribose ring.
    • Biological Function: Universal intracellular second messenger mediating the physiological responses of peptide hormones, catecholamines, and neurotransmitters.

Chemical structure of cyclic adenosine monophosphate illustrating the cyclic 3 prime 5 prime phosphodiester ring

Physiological Functions of Nucleotides

  • Polymeric Precursors:
    • Function as the essential, direct building blocks for the enzymatic synthesis and repair of genetic polymers, DNA\text{DNA} and RNA\text{RNA}.
  • Intracellular Energy Reservoirs:
    • Nucleoside triphosphates serve as cellular energy currency.
    • ATP\text{ATP} provides energy for cellular work, mechanical contraction, active membrane transport, and enzymatic catalysis.
    • GTP\text{GTP} provides specific energy input during ribosomal protein translation, microtubule assembly, and intracellular vesicle trafficking.
  • Second Messengers in Signal Transduction:
    • Cyclic nucleotides (cAMP\text{cAMP} and cGMP\text{cGMP}) transduce extracellular hormonal cues into defined intracellular cascades:
    • Primary hormone binds to a specific target G-protein-coupled receptor on the plasma membrane.
    • Receptor activates the transmembrane effector enzyme adenylate cyclase (adenyl cyclase).
    • Adenylate cyclase cyclizes intracellular ATP\text{ATP} into cAMP\text{cAMP}.
    • Elevated cAMP\text{cAMP} allosterically binds to inactive protein kinase A (PKA\text{PKA}), transforming it into active protein kinase.
    • Active kinase phosphorylates downstream intracellular target proteins, triggering a specific cellular response.

Intracellular signaling cascade showing adenyl cyclase activation, cAMP generation, and protein kinase activation

  • Essential Coenzyme Components:
    • Nucleotide components form the structural scaffolding of redox and acyl-transfer coenzymes:
    • Nicotinamide Adenine Dinucleotide (NAD+\text{NAD}^+ / NADH\text{NADH}): Dinucleotide serving as a mobile hydrogen and electron carrier (2H++2e−2\text{H}^+ + 2\text{e}^-) in catabolic oxidation-reduction reactions, such as the reversible interconversion of lactate and pyruvate catalyzed by lactate dehydrogenase:       Lactate+NAD+⇌Pyruvate+NADH+H+\text{Lactate} + \text{NAD}^+ \rightleftharpoons \text{Pyruvate} + \text{NADH} + \text{H}^+
    • Flavin Adenine Dinucleotide (FAD\text{FAD} / FADH2\text{FADH}_2): Hydrogen carrier participating in intermediate metabolism and oxidative phosphorylation.
    • Coenzyme A (CoA-SH\text{CoA-SH}): Nucleotide-derived carrier providing a reactive thiol group to bind and transfer acyl and acetyl groups.

Reversible interconversion between lactate and pyruvate coupled to NAD+ reduction and NADH oxidation

  • Metabolic Activation of Intermediates:
    • Nucleotides covalently bond to biosynthetic intermediates to form high-energy activated complexes:
    • UDP-glucose\text{UDP-glucose}: Activated sugar nucleotide required as the glucosyl donor for the biosynthesis of glycogen.
    • CDP-choline\text{CDP-choline} and CDP-ethanolamine\text{CDP-ethanolamine}: Activated cytidine intermediates essential for the de novo synthesis of membrane phospholipids.
  • Chemical Group Donors:
    • Specialized nucleotide conjugates serve as activated donor molecules:
    • PAPS\text{PAPS} provides activated sulfate (−SO3−-\text{SO}_3^-) for sulfolipid synthesis.
    • SAM\text{SAM} provides activated methyl groups (−CH3-\text{CH}_3) for transmethylation reactions.

Synthetic Nucleotide Analogues and Clinical Pharmacology

  • Concept and Chemical Design:
    • Synthetic nucleotide analogues are clinically manufactured molecules produced by modifying either the heterocyclic aromatic base or the pentose sugar moiety.
    • Function as antimetabolites by competing with natural substrates, inhibiting specific biosynthetic enzymes, or incorporating into nascent nucleic acids to induce chain termination or lethal mutations.
  • Anti-Gout Therapy — Allopurinol:
    • Mechanism of Action: Structural analogue of hypoxanthine; acts via substrate competition to inhibit the enzyme xanthine oxidase (XO\text{XO}).
    • Normal Pathway: Xanthine oxidase converts hypoxanthine into xanthine, and subsequently converts xanthine into uric acid.
    • Therapeutic Effect: Allopurinol blocks xanthine oxidase, preventing the accumulation and tissue deposition of insoluble uric acid crystals, thereby effectively treating gout and hyperuricemia.

Competitive inhibition of xanthine oxidase by allopurinol blocking conversion of hypoxanthine to uric acid

  • Antineoplastic Therapy — 5-Fluorouracil (5-FU5\text{-FU}):
    • Mechanism of Action: Halogenated synthetic analogue of uracil containing a fluorine atom at carbon 5 (C5\text{C}5).
    • Enzymatic Blockade: Inhibits the enzyme thymidylate synthase, preventing the methylation of uracil derivatives into thymine.
    • Cascading Effect: Decreased thymine synthesis (↓thymine synthesis\downarrow \text{thymine synthesis}) causes depleted dTTP\text{dTTP} pools, which inhibits DNA\text{DNA} replication (↓DNA synthesis\downarrow \text{DNA synthesis}), arresting the proliferation and growth of rapidly dividing cancer cells (↓growth of cancer cells\downarrow \text{growth of cancer cells}).

Chemical mechanism of 5-fluorouracil blocking the conversion of uracil to thymine

Diagnostic Exercises and Self-Assessment Review

  • Exercise 1: Structural Identification of Nucleosides

Comparative molecular diagrams of adenosine and deoxythymidine for structural identification

  • Structural Component Analysis:
    • Purine Ring: Left molecule (adenosine) shows a bicyclic purine (adenine) ring containing fused six- and five-membered rings.
    • Pyrimidine Ring: Right molecule (deoxythymidine) shows a monocyclic six-membered pyrimidine (thymine) ring containing a 5-methyl5\text{-methyl} substitution.
    • β-N-Glycosidic\beta\text{-N-Glycosidic} Bond: The covalent bond linking atom N9\text{N}9 of adenine to C1′\text{C}1' of ribose (left), and atom N1\text{N}1 of thymine to C1′\text{C}1' of deoxyribose (right).
    • Pentose Sugar (Ribose): Left molecule possesses hydroxyl groups on both C2′\text{C}2' and C3′\text{C}3', identifying it as ribose.
    • Deoxypentose Sugar (2′-Deoxyribose2'\text{-Deoxyribose}): Right molecule displays a hydrogen atom without oxygen at C2′\text{C}2' and a hydroxyl group at C3′\text{C}3', identifying it as 2′-deoxyribose2'\text{-deoxyribose}.
    • Exercise 2: Signal Transduction Pathway Identification

Signaling cascade schematic with missing downstream second messenger intermediate

  • Product Identification: The molecule designated at ?????? is cyclic adenosine monophosphate (cAMP\text{cAMP}).
  • Chemical Nature: A cyclic ribonucleotide monophosphate characterized by an intramolecular 3′,5′-phosphodiester3',5'\text{-phosphodiester} linkage.
  • Physiological Function: Functions as an intracellular second messenger that allosterically binds to and activates inactive protein kinase A (PKA\text{PKA}), triggering phosphorylation cascades that execute the target cellular response.
    • Exercise 3: Coenzyme Identification in Dehydrogenase Reactions

Lactate dehydrogenase redox reaction schematic with missing dinucleotide coenzyme labels

  • Reactant Identification: The oxidized compound entering the forward reaction at the dashed line is NAD+\text{NAD}^+, and the reduced product released is NADH+H+\text{NADH} + \text{H}^+.
  • Chemical Nature: A pyridine dinucleotide coenzyme consisting of two mononucleotides (nicotinamide mononucleotide and adenosine monophosphate) linked via a phosphoanhydride bridge.
  • Physiological Function: Operates as an electron and hydride ion (H−\text{H}^-) carrier, accepting two electrons and one proton (2e−+2H+2\text{e}^- + 2\text{H}^+) during the oxidation of lactate to pyruvate, and releasing them during reversible reduction.